(19)
(11) EP 4 815 947 A2

(12)

(88) Date of publication A3:
26.06.2025

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 24861323.4

(22) Date of filing: 29.11.2024
(51) International Patent Classification (IPC): 
A61K 31/4375(2006.01)
A61P 35/00(2006.01)
A61K 31/519(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/4375; A61K 31/519; A61P 35/00
(86) International application number:
PCT/CN2024/135702
(87) International publication number:
WO 2025/113647 (05.06.2025 Gazette 2025/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 30.11.2023 EP 23307100

(71) Applicant: Scientiam Pharma
75014 Paris (FR)

(72) Inventors:
  • GALONS, Hervé
    75014 Paris (FR)
  • OUMATA, Nassima
    75014 Paris (FR)
  • ZENG, Musheng
    Guangzhou, Guangdong 510060 (CN)
  • ZHANG, Yongmin
    Hangzhou, Zhejiang 311422 (CN)
  • ZHONG, Qian
    Guangzhou, Guangdong 510060 (CN)

(74) Representative: Cabinet Becker et Associés 
25, rue Louis le Grand
75002 Paris
75002 Paris (FR)

   


(54) PHENANTHRIDIN-6-AMINES FOR USE IN THE TREATMENT OF CANCERS EXPRESSING EBV ANTIGENS